<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Effect of Adjuvant Chemotherapy on Survival in Patients With Resected Pancreatic Adenocarcinoma After Multiagent Neoadjuvant Chemotherapy

Default sub title

minute read

by The ASCO Post | January 9, 2023
placeholder

New research found that receiving adjuvant chemotherapy improved survival in patients with pancreatic adenocarcinoma who received curative-intent surgery.

Topics: Press Coverage

Comments